To analyze the prognostic value of these proteins, we compared serum cytokine and DCD levels of early‐stage melanoma patients that remained disease‐free at the end of the follow‐up period, with those obtained from early‐stage patients who developed metastasis. This evidence concerns the gene DCD and melanoma.